Li Y H, Jia W D
Department of General Surgery, The First People's Hospital of Hefei, Hefei 230001, China.
Division of Liver Surgery, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230001,China.
Zhonghua Gan Zang Bing Za Zhi. 2020 Nov 20;28(11):905-909. doi: 10.3760/cma.j.cn501113-20201022-00573.
With the advent of the era of artificial intelligence, radiomics is an emerging field in which high-throughput imaging data are extracted from different types of images to model and predict clinical prognosis in a non-invasive manner. Currently, this field is in its initial stage of development and lacks standardized assessment criteria, but still remains a promising tool for the future research direction. Radiomics analysis of hepatocellular carcinoma will aid in the early diagnosis, prognostic evaluation and treatment plan, thereby promoting the continuous improvement of clinical treatment strategies, and providing precise treatment methods to improve the survival rate and cure rate of patients. This article introduces the radiomics research process of hepatocellular carcinoma, and discusses its application progress, challenges and future development directions in the precise diagnosis and treatment of hepatocellular carcinoma.
随着人工智能时代的到来,放射组学是一个新兴领域,它从不同类型的图像中提取高通量成像数据,以非侵入性方式对临床预后进行建模和预测。目前,该领域正处于发展初期,缺乏标准化的评估标准,但仍是未来研究方向的一个有前景的工具。肝细胞癌的放射组学分析将有助于早期诊断、预后评估和治疗方案制定,从而推动临床治疗策略的不断改进,并提供精准治疗方法以提高患者的生存率和治愈率。本文介绍了肝细胞癌的放射组学研究过程,并探讨了其在肝细胞癌精准诊断和治疗中的应用进展、挑战及未来发展方向。